Avalo Therapeutics, Inc. (AVTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$14.67
+7.17%
Mkt Cap $147.95M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $59.00K | $59.00K | +0.00% | -$1.54 | -$0.37 | +75.97% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$1.67 | -$2.19 | -31.14% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$1.43 | -$1.92 | -34.27% |
| Q2 2025 May 12, 2025 | — | — | — | -$1.07 | -$1.25 | -16.82% |
| Q2 2025 Apr 4, 2025 | — | $192.00K | — | $0.58 | -$7.95 | -1470.69% |
| Q4 2024 Nov 7, 2024 | — | $249.00K | — | -$1.19 | -$2.83 | -137.82% |
| Q3 2024 Aug 12, 2024 | — | — | — | -$6.70 | -$14.07 | -110.00% |
| Q3 2024 Jul 11, 2024 | — | — | — | — | -$141.14 | — |
| Q2 2024 May 13, 2024 | — | $571.00K | — | -$1.18 | -$5.98 | -406.78% |
| Q4 2023 Nov 9, 2023 | $300.00K | $236.00K | -21.33% | -$261.90 | -$26.19 | +90.00% |
| Q3 2023 Aug 3, 2023 | $500.00K | $643.00K | +28.60% | -$214.29 | -$140.48 | +34.44% |
| Q2 2023 May 4, 2023 | $1.00M | $475.00K | -52.50% | -$230.95 | -$202.38 | +12.37% |
| Q1 2023 Mar 29, 2023 | $3.61M | $896.00K | -75.18% | -$123.81 | -$247.62 | -100.00% |
| Q4 2022 Nov 7, 2022 | $1.26M | $14.95M | +1088.08% | -$245.24 | $80.95 | +133.01% |
| Q3 2022 Aug 4, 2022 | $1.19M | $1.03M | -12.94% | -$428.57 | -$328.57 | +23.33% |
| Q2 2022 May 5, 2022 | $645.50K | $1.17M | +81.72% | -$400.16 | -$571.66 | -42.86% |
| Q1 2022 Mar 2, 2022 | $1.02M | $219.00K | -78.49% | -$1.90 | -$1.92 | -1.05% |
| Q4 2021 Nov 9, 2021 | $810.00K | $1.35M | +66.67% | -$543.07 | -$485.91 | +10.53% |
| Q3 2021 Aug 2, 2021 | $3.35M | $3.35M | +0.00% | -$2.04 | -$2.16 | -5.88% |
| Q2 2021 May 13, 2021 | $369.69K | $473.00K | +27.95% | -$2.32 | -$3.84 | -65.52% |
| Q1 2021 Mar 8, 2021 | $1.00M | $1.50M | +49.70% | -$1.80 | -$2.16 | -20.00% |
| Q4 2020 Nov 9, 2020 | $1.03M | $1.11M | +7.76% | -$1.14 | -$2.04 | -78.95% |
| Q3 2020 Aug 6, 2020 | $1.12M | $1.34M | +19.74% | -$1.26 | -$2.28 | -80.95% |
| Q2 2020 May 7, 2020 | $809.96K | $2.75M | +240.02% | -$1.22 | -$4.08 | -234.43% |
| Q1 2020 Mar 11, 2020 | $15.75M | -$8.72M | -155.39% | $0.84 | $0.36 | -57.14% |
| Q4 2019 Nov 14, 2019 | $10.42M | $5.61M | -46.15% | -$1.60 | -$0.84 | +47.50% |
| Q3 2019 Aug 8, 2019 | $1.77M | $4.45M | +151.16% | -$1.74 | -$1.32 | +24.14% |
| Q2 2019 May 9, 2019 | $3.17M | $5.41M | +70.66% | -$1.96 | -$1.56 | +20.41% |
| Q1 2019 Mar 18, 2019 | $1.95M | $4.98M | +155.29% | -$0.60 | -$2.16 | -260.00% |
| Q4 2018 Nov 13, 2018 | — | $4.07M | — | — | -$2045.02 | — |
| Q3 2018 Aug 9, 2018 | — | $4.79M | — | — | -$536.57 | — |
| Q2 2018 May 11, 2018 | — | $4.48M | — | — | -$357.08 | — |
| Q2 2018 Apr 2, 2018 | — | $2.23M | — | — | -$1.19 | — |
| Q4 2017 Nov 6, 2017 | — | $25.04M | — | — | $6.30 | — |
| Q3 2017 Aug 14, 2017 | — | $157.80K | — | — | -$1.63 | — |
| Q2 2017 May 9, 2017 | $748.19K | $384.21K | -48.65% | -$4.44 | -$2.28 | +48.65% |
| Q1 2017 Mar 14, 2017 | $673.73K | $182.00K | -72.99% | -$8.04 | -$2.16 | +73.13% |
| Q4 2016 Nov 8, 2016 | $234.23K | $321.50K | +37.26% | -$6.12 | -$8.40 | -37.25% |
| Q3 2016 Aug 15, 2016 | $698.08K | $650.49K | -6.82% | -$5.34 | -$4.92 | +7.87% |
| Q2 2016 May 16, 2016 | — | — | — | -$3.96 | -$7.08 | -78.79% |
| Q1 2016 Mar 23, 2016 | — | — | — | -$3.36 | -$6.36 | -89.29% |
| Q4 2015 Nov 13, 2015 | — | — | — | — | -$0.96 | — |
| Q2 2015 Jun 30, 2015 | — | — | — | — | -$7.55 | — |
| Q1 2015 Mar 31, 2015 | — | — | — | — | -$8.39 | — |
| Q4 2014 Dec 31, 2014 | — | — | — | — | -$6.54 | — |
| Q3 2014 Sep 30, 2014 | — | — | — | — | -$15.14 | — |
| Q2 2014 Jun 30, 2014 | — | — | — | — | -$10.53 | — |
| Q1 2014 Mar 31, 2014 | — | — | — | — | -$9.40 | — |
| Q4 2013 Dec 31, 2013 | — | $14.11M | — | — | -$14.03 | — |
| Q4 2012 Dec 31, 2012 | — | — | — | — | -$47.95 | — |